News and information about universal access to health care; the impact of restrictive policies and financial challenges on access to treatment; drug stock-outs; and scaling up services.

Access to medicines and treatment: latest news

Access to medicines and treatment resources

Access to medicines and treatment features

Access to medicines and treatment news from aidsmap

More news

Access to medicines and treatment news selected from other sources

  • Trading in Venezuela's pain: Border vendors do brisk business in meds

    With the HIV virus killing him, Giovanni Plaza fled Venezuela and was able in neighboring Colombia to receive desperately needed anti-retroviral medicine for free. Some of his compatriots have not been as lucky -- reduced to buying smuggled drugs of dubious quality.

    11 February 2019 | France 24
  • Allowing Insurers to Dictate Therapies Harms People Living with HIV

    A new proposed rule by the Trump Administration could give insurance companies the power to restrict access to medications that people living with HIV need. Under the proposal, insurance companies could also require “prior authorization” and/or “step therapy,” which would force patients to use and fail cheaper therapies before getting access to more effective ones.

    29 January 2019 | BETA blog
  • UK court dismisses AbbVie's legal challenge against the NHS

    The High Court has dismissed a legal challenge by US pharmaceutical firm AbbVie against the National Health Service (NHS) England's procurement deal for drugs to treat and cure hepatitis C. The decision means that the plan to eliminate the virus in England remains on track.

    25 January 2019 | The Lancet (free registration required)
  • South Africa’s drug ATMs offer formula to treat chronic illness

    Dispensing machines in malls save time and ease pressure on health system.

    24 January 2019 | Financial Times
  • Indonesia turns to Global Fund to ensure ARV stock

    Amid rising concerns about the availability of antiretroviral (ARV) therapy drugs following a failed drug tender, the government has given assurances that stocks are enough until the end of this year.

    23 January 2019 | The Jakarta Post
  • Australia will never be HIV-free if access to prevention requires a medicare card

    My research shows newly arrived Asian-born gay and bisexual men are four times more likely to become HIV positive in the four years after arriving in Australia compared to their local peers. Temporary visa holders are not eligible for Medicare, but to access PrEP or HIV treatment cheaply in Australia you need a Medicare card.

    23 January 2019 | The Conversation
  • Revealed: UK patients stockpile drugs in fear of no-deal Brexit

    Ministers have been urged by top doctors to reveal the extent of national drug stocks, amid growing evidence patients are stockpiling medication in preparation for a no-deal Brexit. The Royal College of Physicians (RCP), which represents tens of thousands of doctors, urged the government to be more “transparent about national stockpiles, particularly for things that are already in short supply or need refrigeration, such as insulin”.

    18 January 2019 | The Guardian
  • HIV care: Karnataka bags top spot

    When it comes to providing care, support and treatment to HIV patients, Karnataka has been judged the best performer among states with a high HIV burden.

    16 January 2019 | Times of India
  • Indonesia seeks to reassure HIV patients over drug supplies

    Indonesia’s health ministry has sought to reassure HIV patients that sufficient antiretroviral (ARV) drugs will be available for their treatment after some hospitals had run out of supplies.

    14 January 2019 | Reuters
  • BASHH, BHIVA, HIVPA and NHIVNA statement on management of antiretroviral supplies in preparation for a no-deal Brexit Scenario

    Clinicians do not need to issue longer, or earlier than usual, prescriptions and patients should be reassured that there is no need for concern about the supply of their medication and therefore no need to stockpile.

    11 January 2019 | British HIV Association
More news
Tell us why you visited aidsmap today
minimise

Could you help us by answering three questions on why you’ve visited aidsmap today?

You can close this questionnaire and come back to it later. Just click on the pink circle.

What prompted you to visit aidsmap today?

What exactly are you looking for? What specific questions do you need answered?

Have you found what you were looking for?

close

Thank you for your feedback

Thank you very much for taking time to fill in this questionnaire. NAM really values your feedback. It helps make the information we provide better.

If you have any other comments on the content of this website, we would be interested to hear from you. Please email info@nam.org.uk.

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.